Initial Panitumumab Plus Fluorouracil, Leucovorin, and Oxaliplatin or Plus Fluorouracil and Leucovorin in Elderly Patients With RAS and BRAF Wild-Type Metastatic Colorectal Cancer: The PANDA Trial by the GONO FoundationSara Lonardi, M. Frisinghelli, Cosimo Rasola et al.|Journal of Clinical Oncology|2023Cited by 41
Cisplatin-gemcitabine-durvalumab reintroduction in advanced biliary tract cancer: a multinational real-world analysisSilvia Camera, G. Aprile, F. Nichetti et al.|ESMO Open|2026Cited by 0
Exploring the Role of Surgery After Systemic Therapy in Locally Advanced Biliary Tract Cancer: Outcomes From a Large Retrospective Multinational Real‐World Cohort Treated With Cisplatin, Gemcitabine, and DurvalumabMargherita Rimini, Gian Paolo Spinelli, Angela Lamarca et al.|International Journal of Cancer|2026Cited by 0
Outcomes of Cisplatin, Gemcitabine, and Durvalumab According to <scp>TOPAZ</scp> ‐1 Study Eligibility: A Large Global Analysis in a Real‐World SettingFederica Lo Prinzi, Gian Paolo Spinelli, Margherita Rimini et al.|International Journal of Cancer|2026Cited by 0